Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 395
Selected: 0
NCT IDTitle
NCT00003098Diet and Estrogen Metabolism in Postmenopausal Women
NCT04185311Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted
NCT02681328Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules
NCT04469764Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
NCT00003409Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT06650163Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
NCT00022685Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma
NCT00612001Vaccine Therapy in Treating Patients With Malignant Glioma
NCT00020787Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer
NCT02224911Use of Laser Interstitial Thermal Therapy in the Focal Treatment of Localized Prostate Cancer
NCT06788938Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms
NCT00003320Radiation Therapy Following Surgery to Remove Brain Metastases
NCT00020800Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia
NCT01990196Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer
NCT01059513Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer
NCT01525264Breast Cancer Screening Intervention
NCT00012116Temozolomide in Treating Patients With Solid Tumors That Have Spread to the Brain
NCT04007029Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia
NCT01013285Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
NCT07339085Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis
NCT06047509Focal Laser Ablation of Prostate Cancer: A Feasibility Study Using MRI/US Image Fusion for Guidance
NCT04282824Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate Cancer
NCT04399824Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer
NCT00004979Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors
NCT00005079Timing of Menstrual Cycle and Surgery in Treating Premenopausal Women With Stage I, Stage II, or Stage III Breast Cancer
NCT00045318Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction
NCT00049257Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
NCT04712851Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia
NCT00049322Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery
NCT07310004Virtual Reality vs. Music Relaxation for Reducing Anxiety and Pain During Breast Biopsies
NCT00003225Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer
NCT00084747Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma
NCT0373235218F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma
NCT00040989BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer
NCT04299620Micro-Ultrasound for the Detection and Localization of Prostate Cancer Tumors in Patients Undergoing Radical Prostatectomy
NCT03830918Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy
NCT00020852Cryosurgery in Treating Women With Breast Lesions
NCT00005629Vaccine Therapy in Treating Patients With Liver Cancer
NCT00060294Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's Macroglobulinemia
NCT04705025Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer
NCT03029481Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma
NCT05688215Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
NCT00345826Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia
NCT04069923OsteoCrete in Filling Bone Voids in Participants With Bone Voids or Defects
NCT00021268Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer
NCT04777708BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer
NCT00004889Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
NCT03672773Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer
NCT02310594Anti-tumor Immune Response in Patients With Cancer Undergoing Radiation Therapy
NCT02826395C11 Sodium Acetate PET/CT Imaging of PCa